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Human aquaporin 2 (AQP2) is a water channel found in the kidney
collecting duct, where it plays a key role in concentrating urine.
Water reabsorption is regulated by AQP2 trafficking between
intracellular storage vesicles and the apical membrane. This pro-
cess is tightly controlled by the pituitary hormone arginine vaso-
pressin and defective trafficking results in nephrogenic diabetes
insipidus (NDI). Here we present the X-ray structure of human
AQP2 at 2.75 Å resolution. The C terminus of AQP2 displays mul-
tiple conformations with the C-terminal α-helix of one protomer
interacting with the cytoplasmic surface of a symmetry-related
AQP2 molecule, suggesting potential protein–protein interactions
involved in cellular sorting of AQP2. Two Cd2+-ion binding sites
are observed within the AQP2 tetramer, inducing a rearrangement
of loop D, which facilitates this interaction. The locations of sev-
eral NDI-causing mutations can be observed in the AQP2 structure,
primarily situated within transmembrane domains and the major-
ity of which cause misfolding and ER retention. These observations
provide a framework for understanding why mutations in AQP2
cause NDI as well as structural insights into AQP2 interactions that
may govern its trafficking.
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Water is the major ingredient of the human body, consti-tuting 55–65% of our total body weight (1). Water ho-
meostasis is maintained by the kidneys, which filter ∼180 L of
primary urine every day. Although most water is constitutively
reabsorbed in the proximal tubules and descending limbs of
Henle (2), the body’s water balance is fine-tuned by regulated
water reabsorption, which takes place in the kidney collecting
duct. Water reabsorption is mediated by aquaporins, membrane-
bound water channels, of which seven of the 13 human isoforms
have been located in the human kidney (3). Of these, human
aquaporin 2 (AQP2) is present in the principal cells of the col-
lecting duct and is responsible for regulated water reabsorption.
AQP2 is stored in intracellular vesicles under water-saturating
conditions. When the levels of the pituitary antidiuretic hormone
arginine vasopressin (AVP) are elevated in response to dehydration
or hypernatremia, AVP binding to the vasopressin 2 receptor
(V2R) in the basolateral membrane stimulates an increase in
intracellular cAMP. This triggers the phosphorylation of
Ser256 in the AQP2 C terminus by protein kinase A (PKA)
and flags the protein for trafficking from storage vesicles to the
apical membrane (4–6). AVP also triggers additional phos-
phorylation at Ser264 and Ser269 (7, 8), with all three sites being
phosphorylated in AQP2s targeted to the plasma membrane (9).
The resulting redistribution of AQP2 increases transcellular water
permeability and concentrates urine (Fig. S1). Once correct water
balance is restored, AQP2 is internalized through ubiquitin-
mediated endocytosis and redirected to storage vesicles or tar-
geted for degradation (10–12).
Because of its central role in water homeostasis, dysregulation
of AQP2 is implicated in several human disease states including
congestive heart failure, liver cirrhosis, and preeclampsia (13).
Failure to recruit AQP2 to the apical membrane underlies ac-
quired and congenital nephrogenic diabetes insipidus (NDI),
a water balance disorder in which patients lack the ability to
concentrate urine, leading to severe dehydration (14). Although
congenital NDI is most commonly caused by mutations in the
gene for the V2R receptor, around 10% of NDI patients harbor
AQP2 gene mutations. NDI-causing AQP2 mutations either in-
terfere with its shuttling from storage vesicles to the apical
membrane or, more frequently, cause misfolding and retention
in the endoplasmic reticulum (ER) (15, 16).
Here we present the X-ray structure of human AQP2 at 2.75 Å
resolution, providing a structural framework that contributes to
our understanding of AQP2 trafficking as well as gives insight
into the mechanism of how AQP2 mutations induce NDI. This
structure reveals significant positional variability of the short
AQP2 C-terminal helix. In one protomer, this region interacts
with the cytoplasmic surface of a symmetry-related AQP2 mol-
ecule, an interaction that may mimic protein–protein inter-
actions involved in AQP2 cellular sorting. Moreover, two Cd2+
ions (presumably Ca2+ in vivo) are observed to bind the AQP2
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tetramer and stabilize a specific conformation of the cytoplasmic
loop D that is necessary for this interaction to occur. Radioligand
binding studies show that oocytes expressing AQP2 bind Ca2+,
supporting Ca2+ as the physiological ligand for these sites. Sev-
eral interactions that lead to NDI when disrupted by mutation
are also highlighted. Together, this structure provides insights
into AQP2 mutations in NDI and opens new opportunities to
study the structural mechanism behind membrane protein sort-
ing, including ER recognition of misfolded proteins.
Results
Crystallization of AQP2.Human AQP2 expressed in insect cells (17)
has previously yielded 2D crystals diffracting to 4.5 Å resolution
(18). Extensive efforts to produce better diffracting 3D crystals
using full-length human AQP2 produced in insect cells failed to
sufficiently improve the diffraction. AQP2 was therefore C-ter-
minally truncated at Pro242 and expressed in Pichia pastoris.
Pro242 corresponds to the last visible residue in the structure of
human AQP5 (19), AQP2’s closest paralog with which it shares
63% sequence identity (19). With this truncated AQP2, significant
improvement in diffraction quality was achieved. Complete data to
2.75 Å were collected on a single frozen crystal (Table 1), yielding
a molecular replacement solution using a homology model based
on human AQP5 (19). Iterative rounds of manual rebuilding and
structural refinement resulted in a model with an R-factor and
free R-factor of 20.2% and 22.5%, respectively (for typical
electron density, see Fig. S2). Of particular significance, these
crystals belonged to the space group P42 with one tetramer in the
asymmetric unit, whereby structural differences between in-
dividual protomers within the tetramer can be observed.
Crystal Structure of AQP2. AQP2 displays the conserved aquaporin
fold, assembling as a tetramer with each protomer consisting of
six transmembrane helices. Two half-membrane spanning helices,
formed by loops B and E, constitute a seventh pseudotransmem-
brane segment (Fig. 1 A and B). Each protomer contains a water-
conducting pore through which water is transported in a single file.
Two conserved regions are of particular interest within this pore:
the NPA region, containing two copies of the Asn–Pro–Ala (NPA)
aquaporin signature motif, and the aromatic/arginine selectivity
filter (ar/R), which determines transport specificity (20) (Fig. S3).
When calculated using HOLE (21), all protomers show a similar
pore profile, with the ar/R region constituting its narrowest point
with an average diameter of 1.8 Å (Fig. S4).
C Termini Show Significant Conformational Variability. A striking
difference between the X-ray structure of AQP2 and all other
mammalian AQP structures is the highly variable position of the
short C-terminal helix (Fig. 2A). This flexibility is likely to have
hindered full-length AQP2 from yielding well-diffracting crystals.
The C-terminal helix adopts a unique conformation in each of
the four AQP2 protomers, and in one protomer (D), it is highly
disordered. None of these conformations have previously been
observed in mammalian AQP structures (19, 22–24), for all of
which the C-terminal helix lies across the AQP cytoplasmic
surface with only small variations between structures. In one
protomer, the C-terminal helix interacts with a symmetry-related
AQP2 molecule, forming one of several interactions that are
important for crystal contacts. Specifically, four hydrophobic leu-
cine residues (Leu230, 234, 247, and 240) that align on the same
side of the C-terminal helix of protomer C are sheltered from
exposure to the cytoplasm by this helix inserting into the cyto-
plasmic vestibule on the surface of protomer D of another AQP2
tetramer (Fig. 2B). This interaction is further stabilized by hydro-
gen bonds between side chains and main-chain carbonyls (Fig. S5).
An unusual flexibility in the AQP2 C terminus is likely to arise
from two consecutive prolines (Pro225 and Pro226) that form
a hinge region, whereas only one proline residue is present in the
corresponding position in other mammalian AQP structures. In
particular, the second proline may be functionally important in
AQP2 trafficking, as the P226A mutant caused ER retention
in Madin–Darby canine kidney cells, whereas the P225A mutant
did not (25). However, whether this flexibility is important for
phosphorylation and ubiquitination of the C terminus, events
that are critical for AQP2 trafficking to and from the apical
membrane, remains to be demonstrated.
N Termini Adopt Two Distinct Conformations. For the AQP2 N
terminus, two distinct conformations can be seen (Fig. 2C), al-
though this region is disordered before residue six in protomers
B and C. In protomer A, the N terminus adopts a conformation
allowing hydrogen bond interactions to form between Glu3,
Ser82, and Arg85. This structural triad is also observed in human
AQP5 (19) and in the spinach water channel plasma membrane
intrinsic protein 2;1 (SoPIP2;1) (26), where for the latter it is
proposed to play an important role in the gating mechanism. In
contrast, protomer D of AQP2 adopts a conformation similar to
that seen in AQP1, with transmembrane (TM) helix 1 extending
an additional full turn into the cytoplasm. This conformation
was also observed in the phospho-mimicking S115E mutant of
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Fig. 1. Overall structure of human AQP2. (A) Overview of the AQP2 tetra-
mer with half helices formed by loops B and E highlighted in yellow. (B)
Overview of the AQP2 tetramer from the intracellular side. The color scheme
for each of the protomers is used throughout the article (A, purple; B, ma-
genta; C, pink; D, light pink).
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SoPIP2;1, where the extension of TM helix 1 disrupts a Ca2+
binding site implied in gating (27). The reoccurrence of these two
specific N-terminal conformations among regulated eukaryotic
aquaporins suggests a structural principle governing their regula-
tion. Indeed, the AQP2 N terminus is important for trafficking,
as exchanging both theN and C termini of AQP1 for those of AQP2
was needed to transpose 1-desamino-8-D-arginine vasopressin–
regulated shuttling, a characteristic of AQP2, onto AQP1 (25).
AQP2 Binds Cd2+ at Two Sites. Two prominent peaks, visible at 14 σ
and 8.7 σ, respectively (σ is the SD of the map), were found in
the AQP2 Fobs–Fcalc residual electron density map. Correspond-
ing difference density peaks were also seen in the Fobs–Fobs
anomalous difference density map (9.4 σ and 4.5 σ, respectively),
specifically indicating the presence of a heavy metal. Because
CdCl2 was used as an additive during crystallization, these two
peaks were assigned as Cd2+, with two Cd2+ ions built per tet-
ramer (Cd1 and Cd2) at the cytoplasmic side of the membrane
(Fig. 3A). Cd1 has full occupancy, binds at the membrane in-
terface between protomers A and D, and is ligated by GluA155
of loop D and GlnD57 of TM helix 2, as well as two water
molecules (Fig. 3B). Cd2 has partial (65%) occupancy, is located
between loop B and the C-terminal tail in protomer C, and is
ligated by HisC80, GluC232, and one water molecule (Fig. 3C).
Cd2+ binding clearly influences the structure of loop D, which
adopts different conformations in all four protomers (Fig. S6A).
The binding of Cd1 displaces loop D of protomer A closer to the
center of the AQP2 tetramer, where loop D of protomers A, B,
and D all interact via hydrogen bonds between AsnA156,
AsnD156, and GluB155 (Fig. S6B). In protomer D, this creates
a binding pocket into which the C-terminal helix of a symmetry-
related protomer C binds (Figs. 2B and 3A). Furthermore, the
binding of Cd2 between loop B and the C terminus of protomer
C helps position the C-terminal helix for this interaction (Fig.
3A). Thus, the binding of Cd2+ appears to be important for
interactions between AQP2 tetramers within the crystal and
explains why this additive was critical during crystal optimization.
Oocytes Expressing AQP2 Bind Ca2+. Although Cd2+ binding is
clearly important for crystal formation, this does not necessarily
imply functional significance. A regulatory role for divalent cat-
ions was suggested from the crystal structure of the gated spinach
aquaporin SoPIP2;1 in which binding of Cd2+ was observed to
control the conformation of the gating element loop D (26). For
SoPIP2;1 it was speculated that the Cd2+ ion is replaced by Ca2+
in vivo, and independent studies showed Ca2+ almost completely
abolishing the water transport ability of PIP aquaporins (28).
To test whether AQP2 binds Ca2+, we performed a radioactive
calcium-binding assay. In this assay, either control or AQP2-
expressing Xenopus oocytes were generated and their membranes
isolated and incubated in medium containing 45Ca2+. Following
extensive washing, liquid scintillation counting revealed that signif-
icantly more 45Ca2+ was bound to membranes of AQP2-expressing
oocytes than to those of water-injected controls (Fig. 3D). These
data strongly suggest that AQP2 binds Ca2+ and, as for SoPIP2;1,
imply that the observed Cd2+ binding sites in the AQP2 structure
represent Ca2+ binding sites in vivo.
Discussion
NDI-Causing Mutations in AQP2. NDI is characterized by the in-
ability to concentrate urine and can lead to severe dehydration
unless water intake is increased. Fifty-one different mutations in
the AQP2 gene have been identified in patients suffering from
NDI (15, 16), most of which lead to autosomal recessive NDI
whereby AQP2 is misfolded, retained in the ER, and rapidly
degraded. In some cases, however, ER-retained mutants have
been shown to retain some functionality (29–32), indicating that
the degree of misfolding can be minor.
The locations of thirty-one NDI-causing mutations are iden-
tified in the AQP2 crystal structure, most of which are located
within the transmembrane region (Fig. 4A). These are typically
situated at helix–helix interfaces and presumably disturb packing
interactions and correct folding and/or assembly of the AQP2
tetramer (Fig. S7A). A number of other mutations are found
within the water-conducting pore, affecting key functional resi-
dues such as Asn68, Ala70, and Pro185 of the NPA region or
Arg187 of the selectivity filter, or causing pore narrowing as in
Fig. 2. Structure of the C and N termini. (A) Stereo
image of the four AQP2 protomers (colored as in
Fig. 1) overlaid on OaAQP0 [white; Protein Data
Bank (PDB) ID code 2B60], BtAQP0 (light orange;
PDB ID code 1YMG), BtAQP1 (gray; PDB ID code
1J4N), and HsAQP5 (cyan; PDB ID code 3D9S). The C
termini of all four AQP2 protomers occupy different
positions, none of which overlay with any of the
previous AQP structures. (B) The crystal contact site
between the C-terminal helix of monomer C (pink)
and a symmetry-related protomer D (light pink).
Leucines lining up on one side of the helix are la-
beled. (C) Overlay of the N termini of protomer A
and D with HsAQP5 (cyan) and BtAQP1 (gray). For
protomer A (purple), Glu3 interacts with Ser82 and
Arg85, similar to the structural arrangement seen in
AQP5. In contrast, protomer D (light pink) resembles
BtAQP1 with TM helix 1 extending a full turn into
the cytoplasm.
























the case of V71M and V168M mutations (Fig. S7B). Precisely
how these folding defects are recognized for retention in the ER
and degradation cannot be deduced from the X-ray structure of
only wild-type AQP2.
A small number of NDI-causing mutations are also found
in loop regions. Within the extracellular loop C, mutation of
Thr125 and Thr126 to methionine leads to autosomal recessive
NDI (30, 31). These two threonines are situated close to an
N-glycosylation site at Asn123. When compared against other
mammalian AQPs that lack this glycosylation site, the structure
of loop C is distinctly different for AQP2 (Fig. 4B). Glycosylation
at this site has been suggested to be important for protein sorting
in the Golgi complex, as AQP2–N123Q is retained in this or-
ganelle when expressed in renal cells (33). In oocytes, however,
expression of AQP2–T125M and T126M leads to ER retention
(31, 32), whereas the glycosylation mutant N123Q does not (33),
suggesting that it might not be the lack of glycosylation per se
that causes ER retention but rather mutation-induced structural
changes within loop C.
Within the cytoplasmic loop D, the D150E mutant has been
identified in patients suffering from recessive NDI (34, 35). Our
X-ray structure reveals that Asp150 mediates an interaction
between loop D and the proximal end of the C-terminal tail, with
Asp150 connecting to Pro225 via hydrogen bonds mediated by
Arg152 (Fig. 4C). This interaction is conserved in other mam-
malian AQP structures (19, 22–24, 36). For AQP5, it was argued
that disturbing this interaction might cause structural changes to
the C terminus that flags the protein for trafficking (19). It is
certainly plausible that the bulkier glutamate head group of the
AQP2 D150E mutant would perturb this network of hydrogen
bonds, resulting in structural changes, which could be recognized
by the ER quality control as misfolded protein.
Mutations Near Cd1 Cause ER Retention. Our crystal structure of
AQP2 revealed two unanticipated Cd2+ binding sites per tetra-
mer (Fig. 3A). It is therefore striking that mutation of the Cd1
ligand Gln57 to proline, which disrupts this divalent cation
binding site, has been identified in NDI patients and shown to
cause ER retention in oocytes (37). It is plausible that the loss
of a divalent cation at this site flags AQP2 for ER retention.
Mutation of Ser148, which is situated in a caseine kinase II
consensus site at the cytoplasmic end of TM helix 4, also results
in ER retention (6). The structure reveals that Ser148 of pro-
tomer A interacts with the Cd2+ ligand Gln57 through a direct
hydrogen bond (Fig. 4D). This structural arrangement is strongly
reminiscent of the gated spinach aquaporin SoPIP2;1, for which an
interaction between Ser115 and the Cd2+ ligand Glu31 plays an
important functional role by regulating the opening or closure of
the channel (Fig. S8) (26). In SoPIP2;1, phosphorylation of Ser115
disrupts this interaction and perturbs the Cd2+ binding site, thereby
inducing channel opening through a conformational change of
cytoplasmic loop D (26, 27). Should Ser148 of AQP2 be phos-
phorylated, this could be signaled through a change in protein
structure triggered by disruption of this divalent cation binding site.
An effect of putative phosphorylation of Ser148 of AQP2 was
studied in oocytes by mutating this serine to alanine or aspartate
to abolish or mimic phosphorylation, respectively (6). In these
studies it was observed that the S148A mutant was properly
targeted to the plasma membrane, whereas the S148D mutant
was retained in the ER. Although no evidence for in vivo
phosphorylation of Ser148 has been presented, it is intriguing
that this serine-to-aspartate mutation, which almost certainly
disrupts its interaction with the Cd2+ ligand Gln57, has such
a clear effect on AQP2 trafficking, whereas replacement with
alanine, which should not affect Cd2+ binding, does not. More-
over, an A147T mutation, the site adjacent to Ser148, has been
identified in patients with autosomal recessive NDI, again due to
ER retention of AQP2 (30). Although Ala147 does not directly
interact with any Cd2+ ligand, mutation of this residue might
perturb the Cd2+ binding site. Irrespective of its physiological
significance, it is highly suggestive that missense mutation of
three residues in close proximity to this divalent cation binding
site causes ER retention. This indicates that this region is un-
usually sensitive to perturbations that result in the protein being
viewed as misfolded by the ER quality control.
Potential Role for Ca2+ Binding in AQP2 Trafficking. Although Cd2+
is observed in the AQP2 structure because of its presence in the
crystallization conditions, Ca2+ is a more likely physiological li-
gand. This argument is supported by our results from radioactive
Fig. 3. Cd2+ binding sites in AQP2. (A) Two Cd2+
binding sites (Cd1 and Cd2) are found on the cyto-
plasmic side of the AQP2 tetramer. Yellow spheres
represent Cd2+. The interaction between the C-ter-
minal helix of protomer C (pink) with protomer D
(light pink) of a symmetry-related tetramer is also
shown. (B) Electron density for the Cd1 site show-
ing 2Fobs–Fcalc map contoured at 1.5 σ (blue) and
anomalous difference map contoured at 3.5 σ (or-
ange). Residues serving as Cd2+ ligands are shown in
stick representation. Water molecules ligating the
Cd2+ ion are shown as red spheres. (C) Electron
density for the Cd2 site showing a 2Fobs–Fcalc map
contoured at 1.2 σ (blue) and anomalous difference
map contoured at 3.5 σ (orange). Cd2+ ligands are
displayed as in B. (D) Radioactive Ca2+ binding assay
illustrating how AQP2-expressing Xenopus oocytes
bind significantly more 45Ca2+ (P < 0.05) than con-
trols, suggesting that Ca2+ is the physiological ligand
for the Cd+ binding sites. Mean ± SEM is given of
three groups of 10 oocytes per condition.
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binding assays demonstrating that oocytes expressing AQP2 bind
significantly more Ca2+ than control oocytes (Fig. 3D). Binding
of AVP to the V2R triggers, besides a rise in cAMP level, an
increase in intracellular Ca2+ levels (38–42). Moreover, AVP-
induced plasma membrane sorting of AQP2 is reduced by cal-
modulin and ryanodine receptor inhibitors, indicating that release
of intracellular Ca2+ from ryanodine-sensitive stores is important
for AQP2 targeting to the apical membrane (43, 44). Because the
AQP2 Ca2+ binding sites identified in the crystal structure are
accessible from the cytoplasm, we hypothesize that transient changes
in the intracellular Ca2+ concentration triggers changes in the
structure of AQP2 and that these changes correlate with Ca2+-
dependent targeting of AQP2 to the apical membrane.
LIP5 Interacts with the C-Terminal Helix of AQP2. The presence
of AQP2 in the apical membrane is affected not only by AVP-
stimulated fusion of storage vesicles but also by the internalization
rate upon cessation of the AVP signal. AQP2 internalization
involves ubiquitination of Lys270 at the C terminus, which
enhances endocytosis and targets AQP2 to multivesicular bodies
(MVBs) for subsequent lysosomal degradation (10). A protein
involved in MVB formation is the lysosomal trafficking regulator
interacting protein 5 (LIP5). LIP5 is abundantly expressed in
the collecting duct (45) and has been shown to interact with
AQP2 and facilitate its lysosomal degradation (46).
Biochemical studies have localized the LIP5 binding site of
AQP2 to residues 230–243, all of which are located within the
AQP2 C-terminal helix (46). Moreover, LIP5 is known to bind
proteins containing leucine-rich regions (47), and leucines 230,
234, 237, and 240 all align on the same side of the C-terminal
helix in AQP2 (Fig. 2B). It is therefore intriguing that, for pro-
tomer C, this leucine-rich region interacts with the cytoplasmic
surface of a symmetry-related AQP tetramer. We conclude that
the observed interaction arises from the propensity of the
C-terminal helix to participate in protein–protein interactions
and similar interactions are presumably important in LIP5-
mediated trafficking of AQP2.
An involvement of this short C-terminal helix in protein–
protein interactions has also been reported for the AQP0–
Calmodulin interaction in which one Calmodulin molecule binds
the C-terminal helix from two AQP0 protomers simultaneously
(48, 49). This interaction, which results in reduced AQP0 water
permeability, was shown to be dependent on four hydrophobic
residues (Leu227, Val230, Leu234, and Leu237) aligning on the
same side of the C-terminal helix, as is observed for Leu230,
Leu234, Leu237, and Leu240 in AQP2 (49). Furthermore, these
authors state that rotational movements of the C-terminal helices
are necessary for the interaction to occur. Hence, exposed hy-
drophobic residues on the aquaporin C-terminal helix may well
be a reoccurring motif involved in AQP–protein interactions.
In the case of AQP2, several proteins have been suggested to
interact with the AQP2 C terminus (50–52). Whether or not
these interactions involve hydrophobic interfaces within the
C-terminal helix remains to be shown. Nevertheless, we suggest
that the conformational variability of the AQP2 C terminus seen
in the crystal structure allows for exposure of a variety of binding
surfaces, whereby interaction with a wide range of proteins
can occur.
Conclusion
A major challenge in membrane protein structural biology is to
take the step from understanding the structure–function rela-
tionships of individual membrane proteins to understanding how
these are regulated by posttranslational modification and protein–
protein interactions. AQP2 is the most clinically studied member of
the aquaporin family and is by far the best characterized in terms
of biosynthesis, trafficking from storage vesicles to the apical
membrane and vice versa, degradation, posttranslational mod-
ifications, protein–protein interactions, as well as mutations
in patients suffering from NDI. The crystal structure of AQP2
provides structural insights into all of these phenomena. A
deeper understanding of how AQP2 mutants are recognized and
retained in the ER, or how other proteins such as LIP5 interact
with the C-terminal helix, will require further structural studies
of AQP2 including complex structures with bound interaction
partners. Our structure of AQP2, recovered through rational
modification of the AQP2 construct, both deepens our under-
standing of its function in the human kidney and lays a platform
from which protein–protein interactions regulating a membrane
protein channel activity by trafficking can be explored.
Materials and Methods
Cloning, Overproduction, and Membrane Preparation. C-terminally truncated
human AQP2 was cloned and transformed into P. pastoris. Cells were grown
in a 3 L fermentor typically resulting in 500 g wt cells/L culture after 24 h of
MeOH induction. After harvesting using centrifugation, cells were broken
using a French Press and membranes were pelleted. The resulting mem-
branes were washed in a urea buffer and stored at -80 °C until further use.
For further details, see SI Materials and Methods.
Solubilization, Purification, and Crystallization. Membranes containing AQP2
was solubilized in 2% (wt/vol) n-nonyl-β-D-glucopyranoside (NG) by stirring
for 1 h in an ice bath. AQP2 was purified and concentrated to a final con-
centration of 7.5 mg/mL (SI Materials and Methods). During the last purifi-
cation step, the detergent was changed from NG to octylglucose–
neopentylglycol (OGNPG). Crystals were obtained using the hanging drop
vapor diffusion technique by mixing protein and reservoir [20–30% (vol/vol)
PEG400, 0.1 M Tris pH 8, 0.1 M NaCl, 0.15 M MgCl2] in a 1:1 ratio, with 0.1 M
CdCl2 added to the drop only (SI Materials and Methods). Rod-shaped crys-
tals appeared within a few days. Following cryoprotection (SI Materials
and Methods), crystals were flash frozen in liquid nitrogen and stored for
data collection.
Fig. 4. NDI-causing mutations in AQP2. (A) Overview of known NDI-causing
mutations (yellow) in the AQP2 structure showing how these mostly affect
the pore-forming regions. (B) Structural overlay of loop C from the four
AQP2s showing the N-glycosylation site at Asn123. A comparison with other
mammalian AQPs, here represented by AQP5 (cyan), shows that structure of
AQP2 is markedly different at this site. Asn123 as well as two nearby NDI
mutation sites, Thr125 and Thr126, are shown in stick representation. (C)
Structure around the NDI mutation site at Asp150, showing its connections
to Pro225 at the proximal end of the C-terminal tail via Arg152. Hydrogen
bonds are indicated by dotted lines. Distances are shown in Å. (D) Close-up
of the Cd1 site showing how Ser148 hydrogen bonds to the Cd2+ ligand
Gln57. Mutation of both these residues cause ER retention of AQP2. Bonds
are indicated by dotted lines with distances shown in Å.
























Data Collection and Structural Determination. Complete data at 100 K from
a frozen crystal were collected at European Synchrotron Radiation Facility
(ESRF), Grenoble, France. Crystals belonged to space group P42 with one
tetramer in the asymmetric unit (a = 119.11 Å, b = 119.11 Å, c = 90.48 Å,
α = β = γ = 90°). Following processing and scaling of image data, the
structure was solved by molecular replacement (SI Materials and Methods).
Iterative rounds of refinement and manual model building (SI Materials and
Methods) resulted in a model consisting of four protein chains (A–D) with
the following residues—A2–240, B6–238, C6–241, and D2–233—two Cd2+
ions, one Zn2+ ion, and 59 water molecules. The final R-factor and free
R-factor for this model is 20.2% and 22.5%, respectively.
Radioactive Calcium Binding Assay on Total Membranes of Oocytes. Oocytes
were isolated and injectedwith 10 ngAQP2 cRNA in 50 nLwater per oocyte or
water and cultured for 3 d, after whichmembranes were prepared, incubated
with 45Ca2+, and washed (SI Materials and Methods). Following transfer to
counting tubes, 4 mL of scintillation liquid was added and counted in Tri-
Carb 299 TR liquid scintillation counter. High water permeability confirmed
expression of AQP2. Each value consists of three independent groups of 10
oocytes each. The experiments were performed trice. The difference be-
tween groups was tested by Student t test. A P value < 0.05 was considered
statistically significant.
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